Novo Nordisk A S NVO
NYSE NVO
$38.63 +0.48 (+1.26%)
At close: Oct 9, 2026 · 4:00 PM EDT

Novo Nordisk A S (NVO) Capital Expenditures (2012 - 2018)

Updated

Novo Nordisk A S (NVO) recorded Capital Expenditures of $512 million in Q4 2018, up 8.2% from $473 million a year earlier and up 41.0% from the prior quarter.

Analysis

Novo Nordisk A S (NVO) Capital Expenditures (2012 - 2018) Analysis & Trends

On a TTM basis, Novo Nordisk A S's Capital Expenditures came in at $1.51 billion as of Dec 31, 2018, up 14.7% year-over-year; for FY2016, it came in at $8.23 billion.

  • The Q4 2018 figure is the highest quarterly Capital Expenditures since Q4 2016.
  • On a year-over-year basis, Capital Expenditures rose in six of the last eight quarters, with growth averaging 7.0%.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 68.2% in Q2 2016, against a decline of 94.3% in Q4 2017 at the low end.
  • Per Business Quant, the preceding three quarters came in at $363 million (Q3 2018), $252 million (Q2 2018) and $381 million (Q1 2018).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 512.00 Mn
Sep 30, 2018 363.00 Mn
Jun 30, 2018 252.00 Mn
Mar 31, 2018 381.00 Mn
Dec 31, 2017 473.00 Mn
Sep 30, 2017 327.00 Mn
Jun 30, 2017 285.00 Mn
Mar 31, 2017 230.00 Mn
Dec 31, 2016 8.27 Bn
Sep 30, 2016 268.00 Mn
Jun 30, 2016 254.00 Mn
Mar 31, 2016 161.00 Mn
Dec 31, 2015 6.41 Bn
Sep 30, 2015 186.00 Mn
Jun 30, 2015 151.00 Mn
Mar 31, 2015 115.00 Mn
Dec 31, 2014 3.99 Bn
Sep 30, 2014 176.00 Mn
Jun 30, 2014 148.00 Mn
Mar 31, 2014 127.00 Mn
API Access

Novo Nordisk A S Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NVO&period=max&api_key=YOUR_API_KEY